快速基因组测序与疑似遗传疾病的重症婴儿的基因小组相比:经济评估

Tara A Lavelle1, Jill L Maron2, Stephen F Kingsmore3

  • 1Center for the Evaluation of Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA; Department of Medicine, Tufts University School of Medicine, Boston, MA.

The Journal of pediatrics
|November 2, 2025
PubMed
概括

对患有遗传性疾病的重症婴儿进行早期快速基因组测序 (rGS) 比针对性新生儿基因测序更具成本效益. 这种方法可以在第一年内节省大量的医疗保健成本.